- Report
- July 2024
- 300 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- May 2024
- 120 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- October 2024
- 197 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 191 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 204 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 92 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- January 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- July 2024
- 144 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- July 2024
- 151 Pages
Global
From €3868EUR$4,250USD£3,316GBP
- Conference
- December 2025
- 2 Days
Global
€1568EUR$1,784USD£1,299GBP
€1810EUR$2,058USD£1,499GBP
- Conference
- November 2025
- 1 Day
Global
€784EUR$891USD£649GBP
€904EUR$1,028USD£749GBP
- Conference
- July 2025
- 2 Days
Global
€1568EUR$1,784USD£1,299GBP
€1810EUR$2,058USD£1,499GBP
- Conference
- July 2025
- 1 Day
Global
€784EUR$891USD£649GBP
€904EUR$1,028USD£749GBP
- Conference
- May 2025
- 2 Days
Global
€1810EUR$2,058USD£1,499GBP
- Conference
- May 2025
- 2 Days
Global
€1810EUR$2,058USD£1,499GBP
- Conference
- June 2025
- 2 Days
Europe
€1568EUR$1,784USD£1,299GBP
€1810EUR$2,058USD£1,499GBP
- Conference
- October 2025
- 2 Days
Europe
€1568EUR$1,784USD£1,299GBP
€1810EUR$2,058USD£1,499GBP
- Report
- March 2023
- 254 Pages
Global
From €4769EUR$5,423USD£3,950GBP
- Training
- 60 Minutes
Global

The TMF market within the context of Drug Discovery is a rapidly growing sector of the pharmaceutical industry. It is focused on the development of new drugs and therapies to treat a variety of diseases and conditions. The TMF market is composed of a variety of companies, ranging from large pharmaceutical companies to small biotech firms. These companies are involved in the research and development of new drugs, as well as the manufacturing and distribution of existing drugs.
The TMF market is driven by the need for new and improved treatments for a variety of diseases and conditions. Companies in the TMF market are constantly striving to develop new drugs and therapies that can improve the quality of life for patients. This is done through the use of cutting-edge technologies, such as genomics and proteomics, as well as traditional drug discovery methods.
Some of the companies in the TMF market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, and Sanofi. These companies are involved in the research and development of new drugs, as well as the manufacturing and distribution of existing drugs. Additionally, there are a number of smaller biotech firms that are involved in the TMF market, such as Gilead Sciences, Celgene, and Biogen. Show Less Read more